The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Adrian Wlodarczak
Showing 1-4 of 4 articles
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial
van Geuns R,
Chun-Chin C,
McEntegart M,
Merkulov E,
Kretov E,
Lesiak M,
O’Kane P,
Hanratty C,
Bressollette E,
Silvestri M,
Wlodarczak A,
Barragan P,
Anderson R,
Protopopov A,
Peace A,
Menown I,
Rocchiccioli P,
Onuma Y,
Oldroyd K
April 22, 2022 | 10.4244/EIJ-D-21-00514
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P,
Chang C,
Chevalier B,
West N,
Gori T,
Barbato E,
Tarantini G,
Kocka V,
Achenbach S,
Dudek D,
Escaned J,
Wlodarczak A,
Abdel-Wahab M,
Esposito G,
Tijssen J,
Morice M,
Onuma Y,
van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial
Smits P,
Laforgia P,
Abdel-Wahab M,
Neumann F,
Richardt G,
Boxma-de Klerk B,
Lunde K,
Schotborgh C,
Piroth Z,
Horak D,
Wlodarczak A,
Frederix G,
Omerovic E
June 25, 2020 | 10.4244/EIJ-D-20-00012
Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry
Verheye S,
Wlodarczak A,
Montorsi P,
Bennett J,
Torzewski J,
Haude M,
Vrolix M,
Buck T,
Aminian A,
van der Schaaf R,
Nuruddin A,
Lee M
February 7, 2020 | 10.4244/EIJ-D-18-01058
1
Latest news
AHEAD OF PRINT
Design of the TARGET-FIRST randomised study
FREE ARTICLE - Giuseppe Tarantini et al
March 31, 2023
AHEAD OF PRINT
Oesophageal and gastric injuries in tricuspid TEER
FREE ARTICLE - Tanja Kuecken et al
March 29, 2023
AHEAD OF PRINT
Heavily calcified CTOs: an expert review from the European CTO Club
FREE ARTICLE - Kambis Mashayekhi et al
March 27, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke